NEXGEL, Inc. (NXGL)
$0.38+15.15%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $4M
- Avg volume
- 343.5K
- Beta
- 0.77
- P/E (TTM)
- -0.54
- Short % float
- 1.85%
- Days to cover
- 2.7
- SI change
- -23.7%
- 1W
- +0.00%
- 1M
- -13.64%
- 3M
- -29.63%
- YTD
- -79.01%
- vs SPY 1W
- +1.19%
- vs SPY 1M
- -16.96%
- vs SPY 3M
- -32.02%
- vs SPY YTD
- -90.76%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ANLBUYAdlai Nortye Ltd.RECOVERYQ 14$14.16+3.36%
- EBSSELLEmergent BioSolutions Inc.CRISISQ 12$5.18+1.97%
- BAXBUYBaxter International Inc.RECOVERYQ 1$26.49+0.57%
- MYOBUYMyomo, Inc.CRISISQ -9$1.39-19.65%
- HYFTBUYMindWalk Holdings Corp.RECOVERYQ 8$1.38-2.13%
- PPCBSELLPropanc Biopharma, Inc.CRISISQ -15$1.16+7.41%
- EUDASELLEUDA Health Holdings LimitedCRISISQ -9$15.40+16.58%
- CANFSELLCan-Fite BioPharma Ltd.RECOVERYQ -14$3.35+0.60%
- MOBISELLMobia Medical, Inc. Common StockQ -5$10.98+3.49%
- BDSXBUYBiodesix, Inc.RECOVERYQ -9$25.39-4.66%
- ESPRBUYEsperion Therapeutics, Inc.BULLQ 1$3.18+0.00%
- RNAZSELLTransCode Therapeutics, Inc.CRISISQ -30$2.70-5.92%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 7
- GROWTH
- 16
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-79.9%
REV YoY-
ROE-133.1%
EPS YoY-
ROA-23.4%
GROSS35
OP-45
NET-51
[VALUATION]
P/E TTM-0.54
P/E FWD-
SECTOR PE22.66
INDUSTRY PE41.50
P/B0.69
P/FCF-
EV/EBITDA-4.82
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E150.70
ALTMAN Z-
CURR RATIO0.43
ND/EBITDA-
BETA0.77


